Feasibility of Tetramethylpyrazine in Prevention and Treatment of Alzheimer's Disease Based on Theory of 'Toxin Damaging Brain Collaterals'
|更新时间:2024-06-18
|
Feasibility of Tetramethylpyrazine in Prevention and Treatment of Alzheimer's Disease Based on Theory of 'Toxin Damaging Brain Collaterals'
“The latest research reveals that ligustrazine has potential therapeutic effects on Alzheimer's disease in cardiovascular function, oxidative stress, inflammatory response, and other aspects, providing new ideas for preventing and treating this social problem.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 12, Pages: 209-218(2024)
YIN Jianing,ZHAO Xitong,FAN Wenqian,et al.Feasibility of Tetramethylpyrazine in Prevention and Treatment of Alzheimer's Disease Based on Theory of 'Toxin Damaging Brain Collaterals'[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(12):209-218.
YIN Jianing,ZHAO Xitong,FAN Wenqian,et al.Feasibility of Tetramethylpyrazine in Prevention and Treatment of Alzheimer's Disease Based on Theory of 'Toxin Damaging Brain Collaterals'[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(12):209-218. DOI: 10.13422/j.cnki.syfjx.20240509.
Feasibility of Tetramethylpyrazine in Prevention and Treatment of Alzheimer's Disease Based on Theory of 'Toxin Damaging Brain Collaterals'